Retinal Detachment Market Report 2026

The retinal detachment market size has grown strongly in recent years. It will grow from $2.29 billion in 2025 to $2.45 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of age-related eye disorders, increasing incidence of diabetic retinopathy, wider availability of ophthalmic surgical expertise, expansion of hospital ophthalmology departments, improved access to retinal care services.

The retinal detachment market size is expected to see strong growth in the next few years. It will grow to $3.14 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population, growing adoption of advanced surgical tools, rising investments in ophthalmic research, expansion of specialized retinal centers, increasing demand for early intervention therapies. Major trends in the forecast period include increasing adoption of minimally invasive retinal surgeries, rising use of advanced vitrectomy techniques, growing integration of high-resolution retinal imaging, expansion of early diagnosis and screening programs, enhanced focus on vision preservation outcomes.

The rising volume of eye surgeries is anticipated to drive the growth of the retinal detachment market in the coming years. Eye surgeries are medical procedures carried out to correct visual impairments, manage ocular diseases, or repair eye injuries. The number of eye surgeries is increasing due to prolonged exposure to digital screens, which contributes to digital eye strain and vision deterioration, leading to conditions such as cataracts and myopia that often require surgical intervention. Additionally, lifestyle changes and growing reliance on digital devices are further accelerating the incidence of eye-related disorders. Retinal detachment stimulates advancements in ophthalmic surgery by necessitating the development of innovative surgical techniques and technologies aimed at restoring vision, improving surgical accuracy, and enhancing patient outcomes. For example, in 2023, according to the Eye Bank Association of America, a US-based transplant organization, domestic keratoplasty procedures rose by 2.7%, increasing from 49,597 procedures in 2022 to 50,925 in 2023. Therefore, the increasing number of eye surgeries is fueling the growth of the retinal detachment market.

Major companies operating in the retinal detachment market are concentrating on developing innovative offerings, such as specialized surgical retina services, to improve treatment effectiveness and elevate patient care standards. Surgical retina services involve the establishment of dedicated medical programs or facilities that deliver advanced surgical interventions for retinal disorders. These services focus on the diagnosis and management of retinal conditions, including retinal detachment, macular holes, diabetic retinopathy, and age-related macular degeneration. For instance, in July 2024, NYC Health + Hospitals/Harlem, a US-based teaching hospital, introduced a new Surgical Retina Service to strengthen its ophthalmology capabilities for managing complex retinal conditions within the Harlem community. Launched in collaboration with Columbia University Irving Medical Center’s Edward S. Harkness Eye Institute, which provided technical support, the service emphasizes the diagnosis and treatment of multiple retinal diseases, with retinal detachment being one of the primary indications for retinal surgery.

In April 2024, Carl Zeiss Meditec AG, a Germany-based supplier of ophthalmic medical devices, surgical systems, and digitally integrated workflow solutions, acquired Dutch Ophthalmic Research Center (D.O.R.C.) for an undisclosed amount. Through this acquisition, Carl Zeiss Meditec aims to broaden its global presence in ophthalmology, reinforce its capabilities in anterior and posterior segment surgery, and expand its retina-focused technology portfolio by offering a fully integrated, digitally connected surgical workflow. Dutch Ophthalmic Research Center (D.O.R.C.) is a Netherlands-based company specializing in advanced vitreo-retinal surgical systems, instruments, and consumables, including the EVA NEXUS dual-function platform widely utilized in retinal and combined cataract procedures.

Major companies operating in the retinal detachment market are Alcon Vision LLC, Bausch And Lomb Incorporated, Carl Zeiss Meditec AG, Santen Pharmaceutical Co Ltd, Optos plc, IRIDEX Corporation, Keeler Ltd, Lombart Instrument Inc, Ellex Medical Lasers Ltd, Millennium Surgical Corp, iCare World iCare Finland Oy, Surtex Instruments Limited, Lumibird Medical, NIDEK Co Ltd, ONL Therapeutics Inc, FCI Ophthalmics, Topcon Corporation, Haag Streit Group, Leica Microsystems, Oculus Optikgeraete GmbH, Johnson And Johnson Vision, EssilorLuxottica.

North America was the largest region in the retinal detachment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal detachment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the retinal detachment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the retinal detachment market by increasing the cost of imported ophthalmic surgical instruments, diagnostic imaging systems, vitrectomy devices, and precision consumables used in retinal procedures. Hospitals and specialty eye centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces cost pressures on equipment procurement. These tariffs are increasing procedural costs and affecting capital investment decisions. However, they are also encouraging local manufacturing of ophthalmic devices, regional supplier partnerships, and increased focus on cost-efficient surgical technologies.

The retinal detachment market research report is one of a series of new reports that provides retinal detachment market statistics, including retinal detachment industry global market size, regional shares, competitors with a retinal detachment market share, detailed retinal detachment market segments, market trends and opportunities, and any further data you may need to thrive in the retinal detachment industry. This retinal detachment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Retinal detachment is a medical condition in which the retina, the light-sensitive tissue located at the back of the eye, becomes separated from its underlying supportive layers. This separation interferes with the normal functioning of the retina and can result in vision loss or blindness if not treated in a timely manner.

The main types of retinal detachment include rhegmatogenous retinal detachment, tractional retinal detachment, and exudative retinal detachment. Rhegmatogenous retinal detachment occurs when a tear or hole in the retina allows fluid to enter, causing the retina to detach from the underlying tissue. It is the most common form of retinal detachment and is commonly associated with aging, eye trauma, or severe nearsightedness. Treatment options include photocoagulation, cryopexy, pneumatic retinopexy, scleral buckling, and vitrectomy. These procedures are performed in hospitals, clinics, specialty centers, and other healthcare settings.

The retinal detachment market consists of revenues earned by entities by providing medical services such as diagnosis, surgical treatments, and laser therapies for retinal detachment. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinal detachment market also includes sales of diagnostic equipment, surgical instruments, vitrectomy machines, and anti-inflammatory and anti-VEGF drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.